Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma.
Fuxin LiWei LiKatherine D GrayRasa ZarnegarDan WangThomas J FaheyPublished in: The Journal of international medical research (2021)
FVPTC differs from cPTC in behaviour. Low-dose ablation may be sufficient in FVPTC patients with low-intermediate disease risk.